237 related articles for article (PubMed ID: 15521105)
21. MYB oncogene amplification in hereditary BRCA1 breast cancer.
Kauraniemi P; Hedenfalk I; Persson K; Duggan DJ; Tanner M; Johannsson O; Olsson H; Trent JM; Isola J; Borg A
Cancer Res; 2000 Oct; 60(19):5323-8. PubMed ID: 11034064
[TBL] [Abstract][Full Text] [Related]
22. Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas.
Shivapurkar N; Sood S; Wistuba II; Virmani AK; Maitra A; Milchgrub S; Minna JD; Gazdar AF
Cancer Res; 1999 Aug; 59(15):3576-80. PubMed ID: 10446964
[TBL] [Abstract][Full Text] [Related]
23. TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors.
Sinclair CS; Adem C; Naderi A; Soderberg CL; Johnson M; Wu K; Wadum L; Couch VL; Sellers TA; Schaid D; Slezak J; Fredericksen Z; Ingle JN; Hartmann L; Jenkins RB; Couch FJ
Cancer Res; 2002 Jul; 62(13):3587-91. PubMed ID: 12097257
[TBL] [Abstract][Full Text] [Related]
24. Differential association of BRCA1 and BRCA2 genes with some breast cancer-associated genes in early and late onset breast tumors.
Chunder N; Mandal S; Roy A; Roychoudhury S; Panda CK
Ann Surg Oncol; 2004 Dec; 11(12):1045-55. PubMed ID: 15576832
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of loss of heterozygosity and microsatellite instability RAD52, RAD54 and RAD54B gene and BRCA1 gene mutation in breast cancer].
Romanowicz-Makowska H; Smolarz B
Pol Merkur Lekarski; 2006 Dec; 21(126):548-50. PubMed ID: 17405295
[TBL] [Abstract][Full Text] [Related]
26. BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases.
Ramus SJ; Pharoah PD; Harrington P; Pye C; Werness B; Bobrow L; Ayhan A; Wells D; Fishman A; Gore M; DiCioccio RA; Piver MS; Whittemore AS; Ponder BA; Gayther SA
Cancer Res; 2003 Jan; 63(2):417-23. PubMed ID: 12543797
[TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract][Full Text] [Related]
28. High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutation.
Ingvarsson S; Geirsdottir EK; Johannesdottir G; Sigbjörnsdóttir BI; Eiriksdottir G; Ragnarsson G; Agnarsson BA; Gudmundsson J; Jonasson JG; Sigurdsson A; Egilsson V; Barkardottir RB
Cancer Res; 1998 Oct; 58(19):4421-5. PubMed ID: 9766673
[TBL] [Abstract][Full Text] [Related]
29. Histopathology of BRCA1- and BRCA2-associated breast cancer.
Honrado E; Benítez J; Palacios J
Crit Rev Oncol Hematol; 2006 Jul; 59(1):27-39. PubMed ID: 16530420
[TBL] [Abstract][Full Text] [Related]
30. The accumulation of specific amplifications characterizes two different genomic pathways of evolution of familial breast tumors.
Melchor L; Alvarez S; Honrado E; Palacios J; Barroso A; Díez O; Osorio A; Benítez J
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8577-84. PubMed ID: 16361540
[TBL] [Abstract][Full Text] [Related]
31. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer.
Tseng SL; Yu IC; Yue CT; Chang SF; Chang TM; Wu CW; Shen CY
Genes Chromosomes Cancer; 1997 Dec; 20(4):377-82. PubMed ID: 9408754
[TBL] [Abstract][Full Text] [Related]
32. Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers.
Grushko TA; Blackwood MA; Schumm PL; Hagos FG; Adeyanju MO; Feldman MD; Sanders MO; Weber BL; Olopade OI
Cancer Res; 2002 Mar; 62(5):1481-8. PubMed ID: 11888924
[TBL] [Abstract][Full Text] [Related]
33. Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors.
Krop I; Maguire P; Lahti-Domenici J; Lodeiro G; Richardson A; Johannsdottir HK; Nevanlinna H; Borg A; Gelman R; Barkardottir RB; Lindblom A; Polyak K
Cancer Res; 2003 May; 63(9):2024-7. PubMed ID: 12727813
[TBL] [Abstract][Full Text] [Related]
34. Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH.
Joosse SA; van Beers EH; Tielen IH; Horlings H; Peterse JL; Hoogerbrugge N; Ligtenberg MJ; Wessels LF; Axwijk P; Verhoef S; Hogervorst FB; Nederlof PM
Breast Cancer Res Treat; 2009 Aug; 116(3):479-89. PubMed ID: 18704682
[TBL] [Abstract][Full Text] [Related]
35. A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation.
Alvarez S; Diaz-Uriarte R; Osorio A; Barroso A; Melchor L; Paz MF; Honrado E; Rodríguez R; Urioste M; Valle L; Díez O; Cigudosa JC; Dopazo J; Esteller M; Benitez J
Clin Cancer Res; 2005 Feb; 11(3):1146-53. PubMed ID: 15709182
[TBL] [Abstract][Full Text] [Related]
36. Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data.
Kataki A; Gomatos I; Pararas N; Armakolas A; Panousopoulos D; Karantzikos G; Voros D; Zografos G; Markopoulos C; Leandros E; Konstadoulakis M
Clin Genet; 2005 Apr; 67(4):322-9. PubMed ID: 15733268
[TBL] [Abstract][Full Text] [Related]
37. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
[TBL] [Abstract][Full Text] [Related]
38. Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency.
Beetstra S; Salisbury C; Turner J; Altree M; McKinnon R; Suthers G; Fenech M
Carcinogenesis; 2006 Mar; 27(3):517-24. PubMed ID: 16162645
[TBL] [Abstract][Full Text] [Related]
39. X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors.
Vincent-Salomon A; Ganem-Elbaz C; Manié E; Raynal V; Sastre-Garau X; Stoppa-Lyonnet D; Stern MH; Heard E
Cancer Res; 2007 Jun; 67(11):5134-40. PubMed ID: 17545591
[TBL] [Abstract][Full Text] [Related]
40. Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer.
Han SH; Lee KR; Lee DG; Kim BY; Lee KE; Chung WS
Clin Genet; 2006 Dec; 70(6):496-501. PubMed ID: 17100994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
